ERCC1 expression in triple negative breast carcinoma: the paradox revisited

Breast Cancer Res Treat. 2008 Oct;111(3):569-70. doi: 10.1007/s10549-007-9804-4. Epub 2007 Nov 7.
No abstract available

Publication types

  • Letter

MeSH terms

  • Antineoplastic Agents / therapeutic use
  • Breast Neoplasms / chemistry*
  • Breast Neoplasms / drug therapy
  • Carcinoma / chemistry*
  • Carcinoma / drug therapy
  • DNA-Binding Proteins / analysis*
  • Endonucleases / analysis*
  • Female
  • Humans
  • Immunohistochemistry
  • Patient Selection
  • Platinum Compounds / therapeutic use
  • Receptor, ErbB-2 / analysis*
  • Receptors, Estrogen / analysis*
  • Receptors, Progesterone / analysis*

Substances

  • Antineoplastic Agents
  • DNA-Binding Proteins
  • Platinum Compounds
  • Receptors, Estrogen
  • Receptors, Progesterone
  • ERBB2 protein, human
  • Receptor, ErbB-2
  • ERCC1 protein, human
  • Endonucleases